The Guardian reported that hospitals listed as live and benefiting from Palantir’s federated data platform said the system had not gone live or none of its applications were in use. A less detailed NHS England webpage now describes benefits for early users without the original list.
Palantir’s £330m contract covers a system intended to improve patient outcomes, operating theatre efficiency and bed discharges. The Office for Statistics Regulation is examining NHS claims about its use. The watchdog previously warned that NHS England lacked evidence for a claim that the technology had helped deliver more than 100,000 extra operations.
For companies selling AI into healthcare, the distinction matters: being listed as deployed is not the same as having applications in use. The removal leaves adoption and claimed benefits unresolved; it does not establish that the technology is ineffective.